NCT07382726
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Non-small Cell Lung Cancer
Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
1,362 public trials
335 recruiting studies
Non-small Cell Lung Cancer trial results
NCT06567704
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Atrium Health Levine Cancer Charlotte, North Carolina, United States
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
Recruiting
TCR1188-ABC Cells in KRAS-mutated Cancers
NCT07594067
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +24 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT05877599
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
- Locations
-
- Research Site Gilbert, Arizona, United States
- Research Site Duarte, California, United States
- Research Site Newport Beach, California, United States
- Research Site Santa Monica, California, United States
NCT06634056
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- University Health Network - Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT07412041
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT07111520
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Stanford Cancer Institute Stanford, California, United States
- Yale University New Haven, Connecticut, United States
- Moffit Cancer Center Tampa, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
AB122 Platform Study
NCT04999761
- Conditions
- Advanced or Metastatic Solid Tumor, Alveolar Soft Part Sarcoma, Biliary Tract Cancer, +41 more
- Locations
-
- A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
- A site selected by Taiho Pharmaceutical Co., Ltd. Chiba, Japan
- A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
- A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
NCT07748325
- Conditions
- Adjuvant Therapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
- Suining Central Hospital Suining, Sichuan, China
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Conditions
- Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
- Locations
-
- USOR HonorHealth Phoenix, Arizona, United States
- USOR Arizona Oncology Associates Tucson, Arizona, United States
- University of California Los Angeles Medical Center Los Angeles, California, United States
- University of California, San Diego; Moores Cancer Center San Diego, California, United States